SIL-204's ability to reduce primary tumor growth when administered systemically in orthotopic pancreatic cancer models, where human tumor cells are implanted directly into the pancreas SIL-204's ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback